Ownership history in HAP Trading, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which HAP Trading, LLC reported a position in NEUROCRINE BIOSCIENCES INC (NBIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | REDUCED | 35,884 | -9,616 | -21.1% | 0.42% | $3.97B | $110.60 |
| 2025 Q1 | ADDED | 45,500 | +31,800 | +232.1% | 0.07% | $676.6M | $110.60 |
| 2024 Q3 | ADDED | 13,700 | +100 | +0.7% | 0.00% | $12.6M | $115.22 |
| 2024 Q3 | REDUCED | 13,600 | -45,100 | -76.8% | 0.01% | $118.6M | $115.22 |
| 2020 Q2 | ADDED | 58,700 | +2,800 | +5.0% | 0.10% | $1.8M | $122.00 |
| 2018 Q4 | ADDED | 55,900 | +17,600 | +46.0% | 0.01% | $138K | $71.41 |
| 2017 Q2 | ADDED | 38,300 | +9,500 | +33.0% | 0.00% | $32K | $46.00 |
| 2017 Q2 | REDUCED | 28,800 | -172,000 | -85.7% | 0.00% | $40K | $46.00 |
| 2014 Q4 | INITIATED | 200,800 | — | — | 0.00% | $53K | $22.34 |
As of 2025 Q4 — sorted by position size